Fundraising Fox
EpiBone
New York, US · Founded 2013 · Delaware corporation · 22 employees on LinkedIn · 10 known investors
Find your way into EpiBone
Sign up to see every warm intro you have to EpiBone
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EpiBone team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair. The company translates tissue engineering research into therapeutic products for orthopedic and surgical applications.
Founders & leadership
EpiBone was founded in 2013 by Nina Tandon, Sarindr Bhumiratana, and Gordana Vunjak-Novakovic.
Board
Investors · 10
How we know: Catalytic Impact Foundation's portfolio page · Not right? Tell us
How we know: EMV Capital's portfolio page · Not right? Tell us
How we know: Hackensack Meridian Health Bear's Den's portfolio page · Not right? Tell us
How we know: Kendall Capital Partners's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Lifespan Vision Ventures's portfolio page · Not right? Tell us
How we know: MEDA Angels's portfolio page · Not right? Tell us
How we know: Plum Alley Investments's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$47.8M disclosed across 4 rounds · 2020–2025
▶$4.3MraisedOct 2025 · 131 investors · OtherRule 506(b)
- Robert LangerDirector
- Gordana Vunjak-NovakovicDirector
- Nina TandonExecutive Officer, Director
- Sarindr BhumiratanaExecutive Officer, Director
- David ZhuDirector
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.5MraisedDec 2022 · 51 investors · OtherRule 506(b)
- Nina TandonExecutive Officer, Director, Promoter
- Elma HawkinsDirector
- Robert LangerDirector
- Gordana Vunjak-NovakovicDirector
- Sarindr BhumiratanaExecutive Officer, Director
- David ZhuDirector
- Offering amount
- $36.8M
- Amount sold
- $18.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedFeb 2021 · 4 investors · OtherRule 506(b)
- Nina TandonExecutive Officer, Director, Promoter
- Sarindr BhumiratanaExecutive Officer, Director
- Gordana Vunjak-NovakovicDirector
- Elma HawkinsDirector
- Robert LangerDirector
- Offering amount
- $5M
- Amount sold
- $750K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.3MraisedFeb 2020 · 140 investors · OtherRule 506(b)
- Elma HawkinsDirector
- Sarindr BhumiratanaExecutive Officer, Director
- Nina TandonExecutive Officer, Director, Promoter
- Gordana Vunjak-NovakovicDirector
- Offering amount
- $26.6M
- Amount sold
- $24.3M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as EpiBone.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase II | 2018 | $999.9K |
| Department of DefenseDefense Health Program | Phase I | 2017 | $149K |
| U.S. ArmyArmy | Phase I | 2017 | $99.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $999.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $149.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does EpiBone do?
- EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair. The company translates tissue engineering research into therapeutic products for orthopedic and surgical applications.
- Who founded EpiBone?
- EpiBone was founded by Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic in 2013.
- Who are EpiBone's investors?
- EpiBone's investors include Beresford Ventures, Catalytic Impact Foundation, EMV Capital, Hackensack Meridian Health Bear's Den, Kendall Capital Partners, Lifespan Vision Ventures, MEDA Angels, Plum Alley Investments and 2 more.
- How much funding has EpiBone raised?
- EpiBone has disclosed $47.8M raised across 4 rounds.
- Where is EpiBone headquartered?
- EpiBone is headquartered in New York, US.